Clinical Trial Update: Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir [Phase 3]

View source ↗

Summary

A Phase 3 trial in Egyptian children and adolescents with Hepatitis C genotype 4 evaluated the combination of Sofosbuvir and Daclatasvir; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Yassin Abdelghaffar Charity Center for Liver Disease and Research | Conditions: Hepatitis C Genotype 4 | Phase 3 | Status: COMPLETED